S. Jeurissen MD, S. Bral MD, PhD, K. Vandecasteele MD, PhD, G. De Meerleer MD, PhD, H. Denys MD, PhD
A 53-year old woman presented with an ovarian cancer, FIGO stage IIIc, for which she received a (suboptimal) debulking. Chemotherapy was started, consisting of three-weekly carboplatin-paclitaxel. After four cycles, an interval-debulking was done, which revealed one positive lymph node (out of 21) located interaortocaval. Chemotherapy was resumed, until seven cycles. She had a complete remission, but after four years, she developed positive mediastinal and interaortocaval lymph nodes. She was treated with stereotactic radiotherapy, which resulted in resolution of the lesions and normalisation of the tumour marker. She has no signs of relapse after nearly two years.
This case illustrates that radiotherapy can be an important treatment option in selected patients with oligometastases.